LSE - Delayed Quote USD

Stryker Corporation (0R2S.L)

381.16

+0.93

+(0.24%)

As of June 13 at 6:28:14 PM GMT+1. Market Open.

BSX Q1 Endoscopy Sales Rise 6%: What's Behind the Growth?

Boston Scientific's Q1 2025 Endoscopy sales jump 6%, powered by innovation in stents, clips and surgical tools for GI care.

Zacks 2 days ago

BSX

JNJ

SYK
The Zacks Analyst Blog Highlights Mastercard, Verizon Communications, Stryker, Espey Mfg. & Electronics and Comstock Holding

MA, VZ, SYK, ESP, and CHCI show strength across sectors, with solid growth, tech advances, and strategic positioning in 2025.

Zacks 10 days ago

VZ

MA

SYK
Top Analyst Reports for Mastercard, Verizon & Stryker

MA, VZ, and SYK stand out in today's top analyst picks, fueled by strong growth drivers but tempered by key risks.

Zacks 10 days ago

SYK

VZ

MA
Intuitive Surgical's da Vinci 5: Gaining Precision, Power and Potential

ISRG's da Vinci 5 is gaining momentum with key innovations like Force Feedback and strong Q1 placements boosting adoption.

Zacks 10 days ago

ISRG

SYK

GMED
Why Is Zimmer (ZBH) Down 0.5% Since Last Earnings Report?

Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks 11 days ago

ZBH

SYK
PBH vs. SYK: Which Stock Is the Better Value Option?

PBH vs. SYK: Which Stock Is the Better Value Option?

Zacks 16 days ago

SYK
Jim Cramer on Stryker Corporation (SYK): “I Don’t Like It Enough”

We recently published a list of Jim Cramer Had These 21 Stocks on His Radar. In this article, we are going to take a look at where Stryker Corporation (NYSE:SYK) stands against other stocks that Jim Cramer discusses. When a caller asked about Stryker Corporation (NYSE:SYK), Cramer replied: “I like Stryker, but you know, I […]

Insider Monkey 19 days ago

SYK
Boston Scientific (NYSE:BSX) Q1 Earnings: Leading The Medical Devices & Supplies - Diversified Pack

Let’s dig into the relative performance of Boston Scientific (NYSE:BSX) and its peers as we unravel the now-completed Q1 medical devices & supplies - diversified earnings season.

StockStory 21 days ago

BSX

ABT

NEOG
Stryker wins FDA clearance for minimally invasive back pain treatment

The company will compete with a device Boston Scientific acquired for $850 million.

MedTech Dive 24 days ago

SYK

BSX
Stryker (NYSE:SYK) Expands Pain Therapy With FDA Clearance For OptaBlate BVN System

Stryker (NYSE:SYK) recently secured FDA clearance for its OptaBlate BVN system, aiming to enhance its portfolio in advanced pain therapy solutions. The company's share price rose 14% over the past month. This increase parallels the broader market trends, bolstered by their expansion efforts, such as pursuing mergers and acquisitions and the positive earnings guidance update. Additionally, the declaration of a 5% dividend increase likely provided investor confidence. While the market...

Simply Wall St. 26 days ago

SYK
SYK Stock Likely to Rise Following FDA Clearance for OptaBlate System

Stryker secures FDA clearance for OptaBlate BVN, a groundbreaking nerve ablation system designed to treat chronic vertebrogenic lower back pain with precision and safety.

Zacks 26 days ago

SYK

ITGR

ANGO
Unpacking Q1 Earnings: Baxter (NYSE:BAX) In The Context Of Other Medical Devices & Supplies - Diversified Stocks

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Baxter (NYSE:BAX) and its peers.

StockStory 27 days ago

BAX

BSX

NEOG
Stryker receives FDA clearance for OptaBlate® BVN Basivertebral Nerve Ablation System

Stryker (NYSE:SYK), a global leader in medical technologies, announced that its OptaBlate basivertebral nerve ablation system (OptaBlate BVN) received 510(k) clearance from the U.S. Food and Drug Administration. OptaBlate BVNA is used in a targeted minimally invasive procedure providing long-lasting† vertebrogenic pain relief1. The addition of the OptaBlate BVN to Stryker's pain portfolio expands its advanced pain therapy solutions for patients and is an intersection of its two core competencies

PR Newswire 27 days ago

SYK
SYK Q1 Earnings Call: Stryker Delivers Revenue Beat, Cites International Growth and Tariff Headwinds

Medical technology company Stryker (NYSE:SYK) announced better-than-expected revenue in Q1 CY2025, with sales up 11.9% year on year to $5.87 billion. Its non-GAAP profit of $2.84 per share was 4% above analysts’ consensus estimates.

StockStory last month

SYK
2 Large-Cap Stocks on Our Watchlist and 1 to Think Twice About

Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.

StockStory last month

RBLX

SYK
‘Like driving through the fog’: CEOs discuss how to handle the 90-day pause in the tariff war

Trump launches a new attack on the Fed’s Powell, the Qatar jet issue is not going away.

Fortune last month

SYK
There May Be Reason For Hope In Stryker's (NYSE:SYK) Disappointing Earnings

The market for Stryker Corporation's ( NYSE:SYK ) shares didn't move much after it posted weak earnings recently. Our...

Simply Wall St. last month

SYK
3 Healthcare Stocks to Keep an Eye On

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry has tumbled by 13%. This drop was worse than the S&P 500’s 5.5% loss.

StockStory last month

SYK

LLY
Billionaire Terry Smith, "the English Warren Buffett," Has 31% of His Hedge Fund's Portfolio Invested in 3 Exceptional Stocks

These longtime Fundsmith holdings are still great buys today.

Motley Fool last month

META

MSFT

SYK
Why Stryker Corporation (SYK) Is Among the Best Medical Device Stocks to Buy Now

We recently published a list of 11 Best Medical Device Stocks to Buy Now. In this article, we are going to take a look at where Stryker Corporation (NYSE:SYK) stands against other best medical device stocks to buy now. Trump’s Tariffs Are Dividing the Medical Community On April 16, CNBC reported that Trump’s tariffs are […]

Insider Monkey last month

SYK

Performance Overview

Return	0R2S.L	MSCI WORLD (^990100-USD-STRD)
YTD	+5.71%	+5.40%
1-Year	+12.04%	--
3-Year	+94.91%	+56.91%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Stryker Corporation (0R2S.L)

BSX Q1 Endoscopy Sales Rise 6%: What's Behind the Growth?

The Zacks Analyst Blog Highlights Mastercard, Verizon Communications, Stryker, Espey Mfg. & Electronics and Comstock Holding

Top Analyst Reports for Mastercard, Verizon & Stryker

Intuitive Surgical's da Vinci 5: Gaining Precision, Power and Potential

Why Is Zimmer (ZBH) Down 0.5% Since Last Earnings Report?

PBH vs. SYK: Which Stock Is the Better Value Option?

Jim Cramer on Stryker Corporation (SYK): “I Don’t Like It Enough”

Boston Scientific (NYSE:BSX) Q1 Earnings: Leading The Medical Devices & Supplies - Diversified Pack

Stryker wins FDA clearance for minimally invasive back pain treatment

Stryker (NYSE:SYK) Expands Pain Therapy With FDA Clearance For OptaBlate BVN System

SYK Stock Likely to Rise Following FDA Clearance for OptaBlate System

Unpacking Q1 Earnings: Baxter (NYSE:BAX) In The Context Of Other Medical Devices & Supplies - Diversified Stocks

Stryker receives FDA clearance for OptaBlate® BVN Basivertebral Nerve Ablation System

SYK Q1 Earnings Call: Stryker Delivers Revenue Beat, Cites International Growth and Tariff Headwinds

2 Large-Cap Stocks on Our Watchlist and 1 to Think Twice About

‘Like driving through the fog’: CEOs discuss how to handle the 90-day pause in the tariff war

There May Be Reason For Hope In Stryker's (NYSE:SYK) Disappointing Earnings

3 Healthcare Stocks to Keep an Eye On

Billionaire Terry Smith, "the English Warren Buffett," Has 31% of His Hedge Fund's Portfolio Invested in 3 Exceptional Stocks

Why Stryker Corporation (SYK) Is Among the Best Medical Device Stocks to Buy Now

Performance Overview